Int J Oral Implantol (Berl). 2019;12(2):209-224.
To test a minimally invasive flap in the lateral approach for maxillary sinus floor elevation when compared to a trapezoidal flap.
Each patient received a bilateral sinus elevation procedure based on two different randomly allocated surgical approaches according to a split-mouth design: in the test side, a horizontal incision at mucogingival line was realised; in the control side, a trapezoidal flap was elevated to prepare the lateral window. Each sinus was filled using deproteinised bovine bone and the window covered with a collagen membrane. Implants were inserted according to a two-stage technique 6 months after sinus elevation procedures, submerged and then loaded after 6 months with definitive screw-retained metal-ceramic prostheses. Patients were followed up to 4 months post-loading. Outcome measures included: implant and prosthesis failures, complications, peri-implant marginal bone level changes, residual bone height and width, recorded before sinus augmentation and 180 days post-intervention by computed tomography (CT) scans, surgical times and patient discomfort data, assessed using a visual analogue scale (VAS) diagram for each treated side at 1, 7, 14 and 30 days of follow-up.
Seventeen patients were enrolled in this trial and none dropped out. Five completely edentulous patients were treated with full-arch prosthetic restorations (Toronto dental prosthesis) and 12 patients with partial metal-ceramic screw-retained prostheses. In total 72 implants were inserted, 37 in the test group and 35 in the control group. No prosthesis or implant failures occurred. A total of seven patients showed complications: five of them had complications in both test and control sides. Eight complications were detected in each group. During maxillary sinus elevation procedures, nine interventions (four from the test group and five from the control group) were affected by intrasurgical complications (six membrane perforations and three severe bleedings); post-surgical complications occurred to three patients (one submucosal emphysema in a patient from the test group, one wound dehiscence and a graft infection both recorded in the control group); a total of four implants in two patients in the test group, versus three implants from one patient in the control group showed peri-implant mucositis. There were no statistically significant differences in complications between the two groups (P = 1.00; 95% confidence interval [CI]: 0.15-3.11). Patients from the control group, at 4 months after loading, lost on average 0.53 mm (standard deviation [SD] 0.27; 95% CI: 0.40-0.65), and patients from the test group lost on average 0.66 mm (SD 0.27; 95% CI: 0.53-0.78); the difference was not statistically significant (mean difference: 0.07 mm; SD 0.34; 95% CI: -0.03-0.17; P = 0.102). Significant values for bone augmentation in height, 9.26 mm (SD 1.46; 95% CI: 8.56-9.95) in the test group and 9.38 mm (SD 1.95; 95% CI: 8.45-10.30) in the control group, and width, 1.68 mm (SD 1.04; 95% CI: 1.18-2.20) in the test group and 1.60 mm (SD 1.27; 95% CI: 0.99-2.20) in the control group, were found from the 180-day CT scans. No statistically significant differences were detected between the two groups, either for the bone augmentation data (difference: 0.27 mm; 95% CI: 0.15-0.38; P = 0.60) or for the bone width values (difference: 0.02 mm; 95% CI: 0.07-0.11; P = 0.67). A significant reduction in the total surgical time was found in the test group (mean difference: 6.64 minutes; SD 4.32; 95% CI: 4.58-8.69), with the difference being statistically significant (P = 0.009). Evaluation of patients' postoperative discomfort showed a significant preference for the test procedure: at 1 day the VAS value was 4 (interquartile range [IQR] 2 to 5) in the test group; in the control group the VAS score was 5 (IQR 4 to 8). The intergroup difference was statistically significant (P = 0.002). At the 7-day follow-up, the VAS value was 1 in the test group (IQR 0 to 3) and 3 in the control group (IQR 0 to 7), this difference was statistically significant (P = 0.003). No differences were detected at 14 and 30 days (P > 0.05).
A minimally invasive approach to access the sinus cavity can be as successful as a conventional trapezoidal flap in maxillary sinus floor elevations.
比较微创瓣与梯形瓣在经上颌窦侧壁提升术中的应用。
每位患者均根据双侧随机分配的手术入路(采用劈裂口腔设计)接受了双侧窦提升手术:在实验组中,行牙龈黏膜线的水平切口;在对照组中,行梯形瓣以制备侧窗。每个窦均使用脱蛋白牛骨填充,并使用胶原膜覆盖窗口。根据两段式技术,在窦提升手术后 6 个月植入种植体,6 个月后植入并经潜水式加载,然后用最终的螺钉固位金属-陶瓷修复体加载。患者在加载后 4 个月内进行随访。观察指标包括:种植体和修复体失败、并发症、种植体周围边缘骨水平变化、残留骨高度和宽度,使用计算机断层扫描(CT)扫描在窦提升前和干预后 180 天进行记录,手术时间和患者不适数据,使用视觉模拟量表(VAS)图在每个治疗侧的 1、7、14 和 30 天的随访中进行评估。
本试验共纳入 17 名患者,无脱落病例。5 名完全无牙患者接受全口义齿修复(多伦多义齿),12 名患者接受部分金属陶瓷螺钉固位修复体。共植入 72 个种植体,实验组 37 个,对照组 35 个。无修复体或种植体失败。共有 7 名患者出现并发症:实验组和对照组各有 5 名患者出现并发症。每组均发现 8 例并发症。在经上颌窦提升手术过程中,9 例手术(实验组 4 例,对照组 5 例)出现术中并发症(6 例膜穿孔和 3 例严重出血);术后并发症发生在 3 例患者中(实验组 1 例黏膜下气肿,对照组 1 例创口裂开和 1 例移植感染);实验组有 2 例患者(2 个种植体)和对照组有 1 例患者(1 个种植体)发生种植体周围黏膜炎。两组并发症发生率无统计学差异(P=1.00;95%置信区间:0.15-3.11)。加载后 4 个月,实验组患者平均损失 0.53mm(标准差[SD]0.27;95%置信区间:0.40-0.65),对照组患者平均损失 0.66mm(SD 0.27;95%置信区间:0.53-0.78);差异无统计学意义(平均差值:0.07mm;SD 0.34;95%置信区间:-0.03-0.17;P=0.102)。实验组在高度上的骨增量显著,为 9.26mm(SD 1.46;95%置信区间:8.56-9.95),对照组为 9.38mm(SD 1.95;95%置信区间:8.45-10.30),在宽度上,实验组为 1.68mm(SD 1.04;95%置信区间:1.18-2.20),对照组为 1.60mm(SD 1.27;95%置信区间:0.99-2.20),均来自 180 天的 CT 扫描。两组的骨增量数据(差异:0.27mm;95%置信区间:0.15-0.38;P=0.60)或骨宽度值(差异:0.02mm;95%置信区间:0.07-0.11;P=0.67)均无统计学差异。实验组的总手术时间显著缩短(平均差值:6.64 分钟;SD 4.32;95%置信区间:4.58-8.69),差异具有统计学意义(P=0.009)。对患者术后不适的评估显示,实验组明显更受患者青睐:实验组在第 1 天的 VAS 值为 4(四分位距[IQR]2-5),对照组为 5(IQR 4-8)。组间差异具有统计学意义(P=0.002)。在第 7 天的随访中,实验组的 VAS 值为 1(IQR 0-3),对照组为 3(IQR 0-7),差异具有统计学意义(P=0.003)。在第 14 和 30 天,无差异(P>0.05)。
经上颌窦侧壁微创入路与传统梯形瓣在经上颌窦底提升术中同样有效。